PeeTU

Paediatric Early Phase Clinical Trials Unit

Welcome to the Paediatric Clinical Trials Unit – PeeTU. We are based within the Tampere University Hospital and provide expertise, infrastructure and resources to conduct phase I-II clinical trials in children.

Our major goal is to provide access to early phase clinical trials for children with relapsed or refractory cancers, but we also aim to find novel agents to treat various other conditions in children and adolescents across paediatric subspecialties.

PeeTU will offer centralised clinical trial services (phase I-II) to the whole Finnish paediatric population. All trials are conducted in accordance with Good Clinical Practice (GCP) and in keeping with national and international regulations.

The implementation of EU Paediatric Regulation (EY 1901/2006) increases the need to investagate new medical products via clinical trials in the paediatric population.

Tampere University Hospital

  • Finland has a population of 5,5 million and a child population of 1,2 million. A total of 70 000 children are treated annually in the five university hospitals in Finland.
  • Tampere University Hospital is located in the southern part of Finland and can be easily accessed from all parts of the country.
  • Adult phase I-II clinical trials centre (FONK) was opened at Tays in autumn 2015 and we build on the same infrastructure.
  • In addition to an employed research doctor and a study nurse, a pool of trained paediatric clinical trial nurses are available for new paediatric trials.
  • Finn-Medi Oy provides high-quality administrative services for sponsored clinical trials in close collaboration with the Pirkanmaa Hospital District.
  • A new patient hotel (Norlandia Care Tampere Hotel) in the hospital campus provides a pleasant way to stay overnight for outpatient visits.
  • The new children's hospital is being built with modern and functional facilities and will be opened in 2019.
  • Organized biobanking activity within the hospital (Tampere Biobank).

Persons in charge

Medical Scientist Sauli Palmu
Study Nurse Heidi Alanen
Head of Department Olli Lohi